Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|March 6, 2024
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantationKamal Alzahrani, Oren Pasvolsky, Zhongya Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous TransplantIssa F Khouri, Denái R Milton, Alison M Gulbis, et al.
American Journal of Hematology|July 18, 2023
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experienceOren Pasvolsky, Denái R Milton, Adeel Masood, et al.
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Blood Cancer Journal|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationOren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
Transplantation and Cellular Therapy|January 16, 2023
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center ExperienceOren Pasvolsky, Mahmoud R Gaballa, Denái R Milton, et al.
British Journal of Haematology|July 6, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myelomaCurtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation TherapyGohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Transplantation and Cellular Therapy|May 9, 2021
Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell LymphomaJacinth Joseph, Junsheng Ma, Fady Hennawy, et al.
Transplantation and Cellular Therapy|March 25, 2022
Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Oren Pasvolsky, Junsheng Ma, et al.
Pageof 6